Skip to main content
Fig. 1 | The Egyptian Heart Journal

Fig. 1

From: Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention

Fig. 1

Clinical trial flowchart. *Patients who presented with cardiogenic shock, patients who became candidates for PCI after receiving fibrinolytics, patients who became candidates for emergent coronary artery bypass graft surgery after angiography, patients under 18 years old or over 80 years old, pregnant patients, patients with kidney or liver failure and patients who had contraindications for Eptifibatide use (see main text, methods, patient selection) were excluded from the study. PPCI: Primary Percutaneous Coronary Intervention

Back to article page